VERIPHARM
Board
1 director, 1 in day-to-day management, last change in 2019Director
since 25-06-2025
6-year term from 2025
listed in the 2025 annual accounts, filed on 02-07-2026
Mandates through the years
3 names, the dashed line is todayDirector
Managing director
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
-
- Director, since before 15-07-2019
-
- Managing director, since before 15-07-2019
-
- Director, until 15-07-2019
Control
Capital
- Capital
- €261,500
- Shares
- 615
- Contribution per share
- €425
- Equity per share
- €1,439 in 2025
- Source
- deed of 22-12-2023
Articles of association
deed of 22-12-2023 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directors“Zes jaar, raad van bestuur”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 25 June at 20:00